�Թϲ�����

In the winter of 2022, two parents carried their sick, coughing baby boy into an emergency room deep in California’s Sierra Nevada mountains. The small rural hospital had no pediatric specialists, no pediatric nurses, and no children’s intensive care unit. But it was hours closer than any hospital that did. (Jonathan E. Kohler and Mary A. King, 10/27)

Enough with the TikTokers demanding accommodation for their ‘neurodivergence.’ They’ve built a culture that’s hurting those most in need. (Freddie deBoer, 10/27)

Washington is proposing to subject Chinese pharmaceutical companies to the same national security restrictions already imposed on industries such as semiconductors and artificial intelligence. (Juliana Liu, 10/26)

At the annual European Society for Medical Oncology Congress, a new report brought forward yet another monumental moment in cancer science: A Phase 3 study showed that the “cancer vaccine” intismeran autogene reduced the risk of recurrence or death by 42% compared with pembrolizumab (Keytruda) alone. This is the first neoantigen and mRNA therapy to have met its Phase 3 endpoint in oncology and is part of a collection of well-conducted studies showing promise for cancer therapeutic vaccines. (Karen E. Knudsen and Othman Laraki, 10/27)

A new study shows the benefits of vigorous walking for older adults. (Leana S. Wen, 10/27)